Blood drug levels may predict side effects in skin cancer treatment
NCT ID NCT03610022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 27 people with advanced basal cell skin cancer who were taking the drug vismodegib. The goal was to see if the amount of drug in their blood was linked to side effects like muscle cramps, hair loss, and taste changes. Researchers monitored patients for 6 months to gather this information, which may help doctors adjust doses to reduce side effects in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu de Bordeaux
Bordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could taking breaks from skin cancer drug keep it working?
- Can a smaller dose of this cancer drug still work? new trial aims to find out
- Skin cancer drug sonidegib under safety watch in Real-World study
- New immunotherapy drug could be first defense against advanced skin cancer
- New injection shows promise for Tough-to-Treat skin cancer
- New injections aim to shrink Hard-to-Treat skin tumors